Archer Investment Corporation’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
KFO
Archer Investment Corporation's NEO Position: Q1 2022 in Review
Archer Investment Corporation sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 1,350 shares — an estimated $46.1K sold.
Archer Investment Corporation first reported a position in NEO in Q4 2019 and held it in 9 quarters. The position peaked at $65.1K in Q3 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Archer Investment Corporation reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
- Archer Investment Corporation sold 1,350 NeoGenomics shares in Q1 2022, an estimated $46.1K.
- Archer Investment Corporation first reported a position in NeoGenomics in Q4 2019 and held it in 9 quarters.
- Archer Investment Corporation's NeoGenomics position peaked at $65.1K in Q3 2021.
- 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Archer Investment Corporation's 13F filing for Q1 2022, filed 12 May 2022.